- Home
- SMTI vs ZURA Comparison
SMTI vs ZURA Comparison
Compare SMTI & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- ZURA
- Stock Information
- Founded
- SMTI 1982
- ZURA 2022
- Country
- SMTI United States
- ZURA United States
- Employees
- SMTI N/A
- ZURA N/A
- Industry
- SMTI Medical/Dental Instruments
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SMTI Health Care
- ZURA Health Care
- Exchange
- SMTI Nasdaq
- ZURA Nasdaq
- Market Cap
- SMTI 252.1M
- ZURA 69.9M
- IPO Year
- SMTI N/A
- ZURA N/A
- Fundamental
- Price
- SMTI $29.84
- ZURA $1.31
- Analyst Decision
- SMTI Strong Buy
- ZURA Buy
- Analyst Count
- SMTI 2
- ZURA 7
- Target Price
- SMTI $49.50
- ZURA $14.33
- AVG Volume (30 Days)
- SMTI 51.0K
- ZURA 708.2K
- Earning Date
- SMTI 08-11-2025
- ZURA 08-08-2025
- Dividend Yield
- SMTI N/A
- ZURA N/A
- EPS Growth
- SMTI N/A
- ZURA N/A
- EPS
- SMTI N/A
- ZURA N/A
- Revenue
- SMTI $91,569,883.00
- ZURA N/A
- Revenue This Year
- SMTI $23.53
- ZURA N/A
- Revenue Next Year
- SMTI $5.93
- ZURA N/A
- P/E Ratio
- SMTI N/A
- ZURA N/A
- Revenue Growth
- SMTI 34.65
- ZURA N/A
- 52 Week Low
- SMTI $25.86
- ZURA $0.97
- 52 Week High
- SMTI $39.08
- ZURA $5.07
- Technical
- Relative Strength Index (RSI)
- SMTI 53.37
- ZURA 59.63
- Support Level
- SMTI $29.80
- ZURA $1.00
- Resistance Level
- SMTI $30.94
- ZURA $1.45
- Average True Range (ATR)
- SMTI 1.07
- ZURA 0.10
- MACD
- SMTI 0.29
- ZURA 0.03
- Stochastic Oscillator
- SMTI 73.17
- ZURA 68.89
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.